Target intelligence / Profile preview

Eukaryotic translation termination factor 1 pseudogene (ETF1P1)

Target
ETF1P1
Molecular classification
Pseudogene, Processed pseudogene
01

Overview

The *eukaryotic translation termination factor 1 pseudogene* is a processed pseudogene that shares sequence similarity with the protein-coding ETF1 gene, which encodes eukaryotic peptide chain release factor 1 (eRF1). Pseudogenes such as this do not encode functional proteins due to disabling mutations, truncated coding sequences, or loss of regulatory regions. While the functional ETF1 is a critical component of the translation termination machinery in eukaryotic cells, pseudogenes are typically regarded as nonfunctional relics with no direct biological activity. However, some pseudogenes can have minor roles in gene regulation via RNA molecules, but there is no supporting evidence for such a function for ENSG00000251492. The name "ETF1P1" adheres to standard pseudogene nomenclature and indicates it is a homolog of the ETF1 gene. As a pseudogene, it is neither an enzyme, receptor, transporter, nor any of the classical molecular target families for drug development. It is not considered a biomarker or associated with disease etiology or therapy, and no drugs are known or expected to interact with it. Summary: ENSG00000251492 is a processed pseudogene of the Eukaryotic translation termination factor 1 (ETF1) gene. It does not code for a functional protein, is not considered a therapeutic target, and holds no disease or pharmacological significance.

Other names
HCGVIISUP45L2
02

Mechanism of action

Not applicable

03

Biological functions

No protein-coding function
04

Disease associations

None established

Beyond the preview

Go deeper on Eukaryotic translation termination factor 1 pseudogene (ETF1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation termination factor 1 pseudogene (ETF1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call